10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      CERAMIDE IS METABOLIZED TO ACYLCERAMIDE AND STORED IN LIPID DROPLETS

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          SUMMARY

          In an approach aimed at defining interacting partners of ceramide synthases (CerS), we found that fatty acyl CoA synthase ACSL5 interacts with all CerS. We demonstrate that ACSL5 generated FA-CoA was utilized with de novo ceramide for the generation of acylceramides, poorly studied ceramide metabolites. Functionally, inhibition of ceramide channeling to acylceramide enhanced accumulation of de novo ceramide and resulted in augmentation of ceramide-mediated apoptosis. Mechanistically, we show that acylceramide generation is catalyzed by diacylglycerol acyltransferase 2 (DGAT2) on lipid droplets. In summary, this study identifies a metabolic pathway of acylceramide generation and its sequestration in LD in cells and in livers of mice on a high fat diet. The study also implicates this novel pathway in ceramide-mediated apoptosis, and has implications in co-regulation of triglyceride and sphingolipid metabolisms.

          eTOC Blurb

          XXX et al identify a novel pathway whereby ceramide is converted to acylceramides by a CerS-ACSL-DGAT complex in lipid droplets for storage. These results raise interesting questions as to the metabolic interplay of TG/DAG and ceramide/acylceramide and the roles of ACSL5 and CerS in regulating these balances.

          Related collections

          Most cited references46

          • Record: found
          • Abstract: found
          • Article: not found

          Lipid droplets finally get a little R-E-S-P-E-C-T.

          Long underappreciated as important cellular organelles, lipid droplets are finally being recognized as dynamic structures with a complex and interesting biology. In light of this newfound respect, we discuss emerging views on lipid droplet biology and speculate on the major advances to come.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Triacylglycerol synthesis enzymes mediate lipid droplet growth by relocalizing from the ER to lipid droplets.

            Lipid droplets (LDs) store metabolic energy and membrane lipid precursors. With excess metabolic energy, cells synthesize triacylglycerol (TG) and form LDs that grow dramatically. It is unclear how TG synthesis relates to LD formation and growth. Here, we identify two LD subpopulations: smaller LDs of relatively constant size, and LDs that grow larger. The latter population contains isoenzymes for each step of TG synthesis. Glycerol-3-phosphate acyltransferase 4 (GPAT4), which catalyzes the first and rate-limiting step, relocalizes from the endoplasmic reticulum (ER) to a subset of forming LDs, where it becomes stably associated. ER-to-LD targeting of GPAT4 and other LD-localized TG synthesis isozymes is required for LD growth. Key features of GPAT4 ER-to-LD targeting and function in LD growth are conserved between Drosophila and mammalian cells. Our results explain how TG synthesis is coupled with LD growth and identify two distinct LD subpopulations based on their capacity for localized TG synthesis. Copyright © 2013 Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Many ceramides.

              Intensive research over the past 2 decades has implicated ceramide in the regulation of several cell responses. However, emerging evidence points to dramatic complexities in ceramide metabolism and structure that defy the prevailing unifying hypothesis on ceramide function that is based on the understanding of ceramide as a single entity. Here, we develop the concept that "ceramide" constitutes a family of closely related molecules, subject to metabolism by >28 enzymes and with >200 structurally distinct mammalian ceramides distinguished by specific structural modifications. These ceramides are synthesized in a combinatorial fashion with distinct enzymes responsible for the specific modifications. These multiple pathways of ceramide generation led to the hypothesis that individual ceramide molecular species are regulated by specific biochemical pathways in distinct subcellular compartments and execute distinct functions. In this minireview, we describe the "many ceramides" paradigm, along with the rationale, supporting evidence, and implications for our understanding of bioactive sphingolipids and approaches for unraveling these pathways.
                Bookmark

                Author and article information

                Journal
                101233170
                32527
                Cell Metab
                Cell Metab.
                Cell metabolism
                1550-4131
                1932-7420
                13 April 2017
                07 March 2017
                07 March 2018
                : 25
                : 3
                : 686-697
                Affiliations
                [1 ]Department of Medicine, Stony Brook University, Stony Brook, New York
                [2 ]Stony Brook Cancer Center, Stony Brook University, Stony Brook, New York
                [3 ]Department of Biochemistry, Faculty of Veterinary Medicine, Mansoura University, Mansoura, Egypt
                [4 ]Northport Veterans Affairs Medical Center, Northport, New York
                [5 ]Proteomics Center, Stony Brook University, Stony Brook, New York
                Author notes
                [* ]Lead contact and corresponding author: Lina M. Obeid, Dept. of Medicine, Stony Brook University, Health Science Center, L-4, 179, Stony Brook, NY 11794-8430. Tel.: 631-444-2641; Fax: 631-444-2661; lina.obeid@ 123456stonybrookmedicine.edu
                [6]

                Current Location: Proteomics Shared Resource, Columbia University Medical Center, New York, New York

                Article
                PMC5472424 PMC5472424 5472424 nihpa855413
                10.1016/j.cmet.2017.02.010
                5472424
                28273483
                75472161-e379-4bd4-b50f-2490bd694a87
                History
                Categories
                Article

                Comments

                Comment on this article